Clinical Trial Update: A Study of SKB264 (MK-2870; Sac-TMT) for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (SKB264-II-04) (MK-2870-003) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SKB264 (MK-2870) in advanced or metastatic non-small cell lung cancer. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• SKB264

Snippet

Sponsor: Klus Pharma Inc. | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING